Compare HGSI to:
After Hours: 27.17 N/A (N/A) 3:56pm ET
| Last Trade: | 27.11 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 27.96 |
| Open: | 27.03 |
| Bid: | N/A |
| Ask: | 27.62 x 1000 |
| 1y Target Est: | 32.07 |
| Day's Range: | 27.00 - 27.68 |
|---|---|
| 52wk Range: | 0.45 - 29.48 |
| Volume: | 1,585,499 |
| Avg Vol (3m): | 7,538,950 |
| Market Cap: | 4.47B |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.16 |
| Div & Yield: | N/A (N/A) |
| Fri, Nov 27 | [$$] This Isn't 2003at RealMoney by TheStreet.com |
| Wed, Nov 25 | Human Genome Sciences seeks approval for ZalbinAP |
| Wed, Nov 25 | Human Genome Sciences Submits Biologics License Application to FDA for ZALBINBusiness Wire |
| Tue, Nov 24 | Signals Favor a Santa Claus Rallyat Minyanville.com |
| Tue, Nov 24 | Wall Street's Buy Listat Motley Fool |
| Mon, Nov 23 | Human Genome Sciences and Aegera Therapeutics Announce Initiation of Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Lymphoid TumorsBusiness Wire |
| Sat, Nov 21 | What to Do When the Dow Hits 7,500 Againat Motley Fool |
| Thu, Nov 19 | Credit Cards Party, Bears Smell Blood At E*Tradeat Forbes.com |
| Tue, Nov 17 | UPDATE - Icelandic gene pioneer Decode files for bankruptcyat Reuters |
| Mon, Nov 16 | FDA requests more details on HGSI anthrax drugat bizjournals.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.